March 16, 2020 / 11:56 AM / 2 months ago

BRIEF-BioCryst Pharmaceuticals Says Berotralstat Significantly Reduced Use Of Acute On-Demand Medicine In HAE Patients In Apex-2

March 16 (Reuters) - BioCryst Pharmaceuticals Inc:

* BIOCRYST PHARMACEUTICALS INC - BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below